Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis
Samantha N. Jensen, Nicole Cady, Shailesh K. Shahi, et al.
Science Advances (2021) Vol. 7, Iss. 28
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

The immunology of multiple sclerosis
Kathrine E. Attfield, Lise T. Jensen, Max Kaufmann, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 12, pp. 734-750
Closed Access | Times Cited: 220
The Current and Future Perspectives of Postbiotics
Bing Liang, Dongming Xing
Probiotics and Antimicrobial Proteins (2023) Vol. 15, Iss. 6, pp. 1626-1643
Open Access | Times Cited: 91
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
Lijun Ning, Yilu Zhou, Han Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 70
The gut microbiota in multiple sclerosis varies with disease activity
Florence Thirion, Finn Sellebjerg, Yong Fan, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 62
The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Benedetta Parodi, Nicole Kerlero de Rosbo
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis
Shailesh K. Shahi, Sudeep Ghimire, Peter Lehman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease
Florian Plaza Oñate, Célia Chamignon, Sebastian D. Burz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12232-12232
Open Access | Times Cited: 27
More than a meat- or synthetic nitrogen fertiliser-substitute: a review of legume phytochemicals as drivers of ‘One Health’ via their influence on the functional diversity of soil- and gut-microbes
Rafael D. C. Duarte, Pietro P. M. Iannetta, Ana Gomes, et al.
Frontiers in Plant Science (2024) Vol. 15
Open Access | Times Cited: 9
Dietary Isoflavones Alter Gut Microbiota and Lipopolysaccharide Biosynthesis to Reduce Inflammation
Sudeep Ghimire, Nicole Cady, Peter Lehman, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 32
Fluoride induced leaky gut and bloom of Erysipelatoclostridium ramosum mediate the exacerbation of obesity in high-fat-diet fed mice
Guijie Chen, Yujia Peng, Yujie Huang, et al.
Journal of Advanced Research (2022) Vol. 50, pp. 35-54
Open Access | Times Cited: 32
Feeding the gut microbiome: impact on multiple sclerosis
Matteo Bronzini, Alessandro Maglione, Rachele Rosso, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights
Fatemeh Taghizadeh Ghassab, Fatemeh Shamlou Mahmoudi, Reyhaneh Taheri Tinjani, et al.
Life Sciences (2024) Vol. 350, pp. 122748-122748
Closed Access | Times Cited: 7
Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet
Theresa L. Montgomery, Daniel Peipert, Dimitry N. Krementsov
Immunological Reviews (2024) Vol. 325, Iss. 1, pp. 131-151
Open Access | Times Cited: 6
Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer
Chandra K. Maharjan, Jiao Mo, Lei Wang, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 206-206
Open Access | Times Cited: 35
Isoflavone consumption reduces inflammation through modulation of phenylalanine and lipid metabolism
Rachel L. Shrode, Nicole Cady, Samantha N. Jensen, et al.
Metabolomics (2022) Vol. 18, Iss. 11
Open Access | Times Cited: 23
Game of microbes: the battle within – gut microbiota and multiple sclerosis
Ti-Ara Turner, Peter Lehman, Sudeep Ghimire, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Flavonoids bridging the gut and the brain: Intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration
Giulia Magni, Benedetta Riboldi, Katia Petroni, et al.
Biochemical Pharmacology (2022) Vol. 205, pp. 115257-115257
Open Access | Times Cited: 21
Acidic natural deep eutectic solvents as dual solvents and catalysts for the solubilization and deglycosylation of soybean isoflavone extracts: Genistin as a model compound
Jie Chen, Yishu Ni, Pingjing Zhang, et al.
Food Chemistry (2022) Vol. 406, pp. 134999-134999
Closed Access | Times Cited: 20
Identification of lipid metabolism-related gene markers and construction of a diagnostic model for multiple sclerosis: an integrated analysis by bioinformatics and machine learning
Fangjie Yang, Xin‐Min Li, Jing Wang, et al.
Analytical Biochemistry (2025), pp. 115781-115781
Closed Access
Unveiling roles of beneficial gut bacteria and optimal diets for health
Thallapuranam Krishnaswamy Suresh Kumar, Riya Mukherjee, Pratibha Gaur, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Metabolic insights into gut microbiota in the pharmacology of natural medicines
Zixin Chen, Junchi Zhou, Xiao Zheng, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 2, pp. 158-168
Closed Access
Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential
Mohammad Hossein Nemati, Esmaeil Yazdanpanah, Roya Kazemi, et al.
Biology (2025) Vol. 14, Iss. 4, pp. 435-435
Open Access
How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation
Jessica Rebeaud, Benjamin Peter, Caroline Pot
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10128-10128
Open Access | Times Cited: 17
Molecular mechanisms underlying the potential neuroprotective effects of Trifolium pratense and its phytoestrogen‐isoflavones in neurodegenerative disorders
Ahmed S. Al‐Shami, Amina E. Essawy, Heba‐Tallah Abd Elrahim Abd Elkader
Phytotherapy Research (2023) Vol. 37, Iss. 6, pp. 2693-2737
Closed Access | Times Cited: 10
Systematic Engineering of Saccharomyces cerevisiae for the De Novo Biosynthesis of Genistein and Glycosylation Derivatives
Yongtong Wang, Zhiqiang Xiao, Siqi Zhang, et al.
Journal of Fungi (2024) Vol. 10, Iss. 3, pp. 176-176
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top